Essential hypertension--is erroneous receptor output to blame?

Marcin Ufnal1

  • 1Department of Experimental and Clinical Physiology, Medical University of Warsaw, Krakowskie Przedmiescie 26/28, 00-927 Warsaw, Poland.

Medical Hypotheses
|January 31, 2012
PubMed

Insights

Essential hypertension may stem from the brain receiving incorrect signals about blood pressure. False "low-pressure" input can cause the brain to improperly regulate arterial pressure, leading to hypertension.

Area of Science:

  • Cardiovascular physiology
  • Neuroscience
  • Hypertension research

Background:

  • Hypertension is a chronic condition with elevated systemic arterial blood pressure.
  • Essential (idiopathic) hypertension, lacking a clear cause, accounts for 80-90% of cases.
  • Current understanding of hypertension etiology is incomplete.

Purpose of the Study:

  • To propose a novel hypothesis for the etiology of essential hypertension.
  • To investigate the role of erroneous sensory information in blood pressure regulation.
  • To explore how the brain's interpretation of cardiovascular signals contributes to hypertension.

Main Methods:

  • Hypothetical model development based on physiological principles.
  • Analysis of potential sources of erroneous cardiovascular receptor information.
  • Consideration of evolutionary factors in blood pressure regulation.

Main Results:

  • Hypothesizes that false "low-arterial pressure input" to the brain, despite high systemic pressure, can trigger hypertension.
  • Suggests that impaired cardiovascular receptors, altered receptor activity, or faulty signal transmission cause information errors.
  • Proposes that the brain's pressure-regulating centers reset inappropriately due to erroneous input.

Conclusions:

  • Erroneous cardiovascular sensory information, particularly false "low-pressure" signals, may be a significant factor in idiopathic hypertension.
  • The brain's response to "low-pressure" input may be prioritized due to evolutionary survival mechanisms.
  • This hypothesis offers a new perspective on hypertension pathogenesis and potential therapeutic targets.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...